138 related articles for article (PubMed ID: 17928956)
1. Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal.
Selkirk SM; Morrow J; Barone TA; Hoffer A; Lock J; DeChant A; Mangla S; Plunkett RJ; Miller RH
J Neurooncol; 2008 Feb; 86(3):285-96. PubMed ID: 17928956
[TBL] [Abstract][Full Text] [Related]
2. Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma model.
Lamour V; Le Mercier M; Lefranc F; Hagedorn M; Javerzat S; Bikfalvi A; Kiss R; Castronovo V; Bellahcène A
Int J Cancer; 2010 Apr; 126(8):1797-1805. PubMed ID: 19609945
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.
Yamaguchi Y; Shao Z; Sharif S; Du XY; Myles T; Merchant M; Harsh G; Glantz M; Recht L; Morser J; Leung LL
J Biol Chem; 2013 Feb; 288(5):3097-111. PubMed ID: 23204518
[TBL] [Abstract][Full Text] [Related]
4. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
[TBL] [Abstract][Full Text] [Related]
5. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.
Szulzewsky F; Schwendinger N; Güneykaya D; Cimino PJ; Hambardzumyan D; Synowitz M; Holland EC; Kettenmann H
Neuro Oncol; 2018 Feb; 20(3):355-366. PubMed ID: 29016864
[TBL] [Abstract][Full Text] [Related]
6. New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity.
Henry A; Nokin MJ; Leroi N; Lallemand F; Lambert J; Goffart N; Roncarati P; Bianchi E; Peixoto P; Blomme A; Turtoi A; Peulen O; Habraken Y; Scholtes F; Martinive P; Delvenne P; Rogister B; Castronovo V; Bellahcène A
Oncotarget; 2016 Sep; 7(39):63708-63721. PubMed ID: 27563812
[TBL] [Abstract][Full Text] [Related]
7. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
El-Tanani MK; Jin D; Campbell FC; Johnston PG
Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
Wei J; Marisetty A; Schrand B; Gabrusiewicz K; Hashimoto Y; Ott M; Grami Z; Kong LY; Ling X; Caruso H; Zhou S; Wang YA; Fuller GN; Huse J; Gilboa E; Kang N; Huang X; Verhaak R; Li S; Heimberger AB
J Clin Invest; 2019 Jan; 129(1):137-149. PubMed ID: 30307407
[TBL] [Abstract][Full Text] [Related]
10. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
11. Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis.
Zhao M; Xu H; Liang F; He J; Zhang J
Tumour Biol; 2015 Jan; 36(1):429-36. PubMed ID: 25266800
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy.
Güttler A; Giebler M; Cuno P; Wichmann H; Keßler J; Ostheimer C; Söling A; Strauss C; Illert J; Kappler M; Vordermark D; Bache M
Radiother Oncol; 2013 Sep; 108(3):535-40. PubMed ID: 23891093
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin regulates human glioma cell invasiveness and tumor growth in mice.
Jan HJ; Lee CC; Shih YL; Hueng DY; Ma HI; Lai JH; Wei HW; Lee HM
Neuro Oncol; 2010 Jan; 12(1):58-70. PubMed ID: 20150368
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma.
Yushi Q; Li Z; Von Roemeling CA; Doeppler H; Marlow LA; Kim BY; Radisky DC; Storz P; Copland JA; Tun HW
Oncotarget; 2016 May; 7(22):32156-71. PubMed ID: 27050077
[TBL] [Abstract][Full Text] [Related]
15. The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.
Courter D; Cao H; Kwok S; Kong C; Banh A; Kuo P; Bouley DM; Vice C; Brustugun OT; Denko NC; Koong AC; Giaccia A; Le QT
PLoS One; 2010 Mar; 5(3):e9633. PubMed ID: 20224789
[TBL] [Abstract][Full Text] [Related]
16. Mediation of multiple pathways regulating cell proliferation, migration, and apoptosis in the human malignant glioma cell line U87MG via unphosphorylated STAT1: laboratory investigation.
Ju H; Li X; Li H; Wang X; Wang H; Li Y; Dou C; Zhao G
J Neurosurg; 2013 Jun; 118(6):1239-47. PubMed ID: 23600941
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells.
Wang Y; Yan W; Lu X; Qian C; Zhang J; Li P; Shi L; Zhao P; Fu Z; Pu P; Kang C; Jiang T; Liu N; You Y
Eur J Cell Biol; 2011 Aug; 90(8):642-8. PubMed ID: 21616556
[TBL] [Abstract][Full Text] [Related]
18.
Li Y; Guo S; Zhao K; Conrad C; Driescher C; Rothbart V; Schlomann U; Guerreiro H; Bopp MH; König A; Carl B; Pagenstecher A; Nimsky C; Bartsch JW
Biol Chem; 2021 Jan; 402(2):195-206. PubMed ID: 33544472
[TBL] [Abstract][Full Text] [Related]
19. Identification of therapeutic targets for glioblastoma by network analysis.
Friedmann-Morvinski D; Bhargava V; Gupta S; Verma IM; Subramaniam S
Oncogene; 2016 Feb; 35(5):608-20. PubMed ID: 25961929
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.
Suzuki M; Mose E; Galloy C; Tarin D
Am J Pathol; 2007 Aug; 171(2):682-92. PubMed ID: 17620367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
